KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Times Interest Earned (2018 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Times Interest Earned for 4 consecutive years, with -$4.19 as the latest value for Q2 2020.

  • Quarterly Times Interest Earned rose 85.43% to -$4.19 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was -$103.13 through Mar 2021, down 270.9% year-over-year, with the annual reading at -$16.23 for FY2020, 45.64% up from the prior year.
  • Times Interest Earned for Q2 2020 was -$4.19 at Xenon Pharmaceuticals, up from -$24.34 in the prior quarter.
  • The five-year high for Times Interest Earned was -$4.19 in Q2 2020, with the low at -$49.09 in Q1 2018.
  • Average Times Interest Earned over 3 years is -$28.46, with a median of -$28.8 recorded in 2019.
  • The sharpest move saw Times Interest Earned dropped 17.85% in 2019, then skyrocketed 85.43% in 2020.
  • Over 3 years, Times Interest Earned stood at -$20.92 in 2018, then crashed by 59.28% to -$33.33 in 2019, then skyrocketed by 87.41% to -$4.19 in 2020.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$4.19, -$24.34, and -$33.33 for Q2 2020, Q1 2020, and Q4 2019 respectively.